1. Home
  2. ALTO vs ASMB Comparison

ALTO vs ASMB Comparison

Compare ALTO & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alto Ingredients Inc.

ALTO

Alto Ingredients Inc.

HOLD

Current Price

$5.71

Market Cap

411.2M

Sector

Industrials

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$26.88

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALTO
ASMB
Founded
2003
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.2M
442.9M
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
ALTO
ASMB
Price
$5.71
$26.88
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.20
AVG Volume (30 Days)
2.3M
178.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
119.51
91.78
EPS
0.05
N/A
Revenue
$917,927,000.00
N/A
Revenue This Year
$6.66
N/A
Revenue Next Year
$0.43
$638.39
P/E Ratio
$108.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$15.12
52 Week High
$6.00
$39.71

Technical Indicators

Market Signals
Indicator
ALTO
ASMB
Relative Strength Index (RSI) 64.51 42.79
Support Level $4.27 $26.40
Resistance Level $6.00 $27.14
Average True Range (ATR) 0.33 1.68
MACD 0.08 -0.18
Stochastic Oscillator 83.56 15.37

Price Performance

Historical Comparison
ALTO
ASMB

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: